We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

157 hedge funds and large institutions have $1.86B invested in Foundation Medicine, Inc. in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more funds holding in top 10

Funds holding in top 10: 37 (+4)

88% more capital invested

Capital invested by funds: $986M → $1.86B (+$871M)

66% more call options, than puts

Call options by funds: $87.8M | Put options by funds: $52.8M

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

16% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 38

9% more funds holding

Funds holding: 144157 (+13)

Holders
157
Holders Change
+13
Holders Change %
+9.03%
% of All Funds
3.59%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.16%
New
54
Increased
44
Reduced
38
Closed
41
Calls
$87.8M
Puts
$52.8M
Net Calls
+$34.9M
Net Calls Change
-$33.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Nomura Asset Management
101
Nomura Asset Management
Japan
$547K
IA
102
IFP Advisors
Florida
$513K -$1.14M -12,570 -77%
PSC
103
Prentiss Smith & Co
Vermont
$490K -$3.52M -38,787 -92%
SO
104
STRS Ohio
Ohio
$464K -$772K -8,500 -71%
HPC
105
HM Payson & Co
Maine
$414K +$275K +3,025 New
MTCM
106
Mint Tower Capital Management
Netherlands
$410K +$272K +3,000 New
USAA
107
United Services Automobile Association
Texas
$408K +$271K +2,984 New
Teacher Retirement System of Texas
108
Teacher Retirement System of Texas
Texas
$402K -$25K -275 -9%
BJL
109
Brighton Jones LLC
Washington
$398K
AG
110
Aperio Group
California
$382K +$1.45K +16 +0.6%
Los Angeles Capital Management
111
Los Angeles Capital Management
California
$370K +$246K +2,710 New
WG
112
Winton Group
United Kingdom
$335K -$194K -2,138 -47%
UBS Group
113
UBS Group
Switzerland
$316K -$3.78M -41,658 -95%
AB
114
Amalgamated Bank
New York
$316K +$210K +2,314 New
XK
115
Xact Kapitalforvaltning
Sweden
$314K +$209K +2,300 New
Janney Montgomery Scott
116
Janney Montgomery Scott
Pennsylvania
$309K -$41.3K -455 -17%
VF
117
Virtu Financial
New York
$293K +$195K +2,144 New
FIA
118
FNY Investment Advisers
New York
$287K +$191K +2,100 New
Russell Investments Group
119
Russell Investments Group
United Kingdom
$277K -$1.77M -19,461 -91%
AAM
120
Aureus Asset Management
Massachusetts
$273K +$182K +2,000 New
Prudential Financial
121
Prudential Financial
New Jersey
$257K +$170K +1,877 New
SCM
122
Silvant Capital Management
Georgia
$254K
Canada Life
123
Canada Life
Manitoba, Canada
$232K
ECM
124
Element Capital Management
New York
$227K +$151K +1,661 New
FAIM
125
Financial Advocates Investment Management
Washington
$205K -$182K -2,000 -57%

FMI Hedge Fund Activity: Q2 2018 in Review

157 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2018, worth a combined $1.86B — up 88% from $986M a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new FMI positions and 41 closed out — a net gain of 13 holders — while 44 added to existing stakes and 38 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $33.2M. The largest seller was Oppenheimer & Co, cutting an estimated $63.6M.

  • 157 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2018, up from 144 in Q1 2018.
  • Funds reported $1.86B of Foundation Medicine, Inc. stock for Q2 2018, up 88% quarter-over-quarter.
  • 54 funds opened new Foundation Medicine, Inc. positions in Q2 2018 and 41 closed out, a net change of +13 holders.
  • The largest Foundation Medicine, Inc. buyer in Q2 2018 was JP Morgan Chase, an estimated $33.2M added.
  • The largest Foundation Medicine, Inc. seller in Q2 2018 was Oppenheimer & Co, an estimated $63.6M sold.

Based on aggregated 13F filings for Q2 2018.